Your browser doesn't support javascript.
loading
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3).
Go, Se-Il; Lee, Sang-Cheol; Bae, Woo Kyun; Zang, Dae Young; Lee, Hyun Woo; Jang, Joung Soon; Ji, Jun Ho; Kim, Jung Hoon; Park, Sanggon; Sym, Sun Jin; Yang, Yaewon; Jeon, So Yeon; Hwang, In Gyu; Oh, Sung Yong; Kang, Jung Hun.
Affiliation
  • Go SI; Division of Hematology and Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Lee SC; Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Cheonan, Republic of Korea.
  • Bae WK; Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Republic of Korea.
  • Zang DY; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
  • Lee HW; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Jang JS; Division of Hematology/Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
  • Ji JH; Division of Hematology-Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
  • Kim JH; Division of Hematology/Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
  • Park S; Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Republic of Korea.
  • Sym SJ; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
  • Yang Y; Department of Internal Medicine, Chungbuk University Hospital, Chungbuk University College of Medicine, Cheongju, Republic of Korea.
  • Jeon SY; Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Republic of Korea.
  • Hwang IG; Division of Hematology/Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
  • Oh SY; Department of Internal Medicine, Dong-A University Hospital, Busan, Republic of Korea. Electronic address: drosy@dau.ac.kr.
  • Kang JH; Division of Hematology/Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic address: newatp@gnu.ac.kr.
Eur J Cancer ; 157: 21-30, 2021 11.
Article in En | MEDLINE | ID: mdl-34464782
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Tegafur / Deoxycytidine Type of study: Clinical_trials Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2021 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Tegafur / Deoxycytidine Type of study: Clinical_trials Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2021 Document type: Article Country of publication: United kingdom